Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28447
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMiller, Julie A-
dc.contributor.authorGundara, Justin-
dc.contributor.authorHarper, Simon-
dc.contributor.authorHerath, Madhuni-
dc.contributor.authorRamchand, Sabashini K-
dc.contributor.authorFarrell, Stephen G-
dc.contributor.authorSerpell, Jonathan-
dc.contributor.authorTaubman, Kim-
dc.contributor.authorChristie, James-
dc.contributor.authorGirgis, Christian M-
dc.contributor.authorSchneider, Hans G-
dc.contributor.authorClifton-Bligh, Roderick-
dc.contributor.authorGill, Anthony J-
dc.contributor.authorDe Sousa, Sunita M C-
dc.contributor.authorCarroll, Richard W-
dc.contributor.authorMilat, Frances-
dc.contributor.authorGrossmann, Mathis-
dc.date2021-
dc.date.accessioned2022-01-10T03:24:36Z-
dc.date.available2022-01-10T03:24:36Z-
dc.date.issued2021-12-19-
dc.identifier.citationClinical Endocrinology 2021;en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28447-
dc.description.abstractTo develop evidence-based recommendations to guide the surgical management and postoperative follow-up of adults with primary hyperparathyroidism. Representatives from relevant Australian and New Zealand Societies used a systematic approach for adaptation of guidelines (ADAPTE) to derive an evidence-informed position statement addressing eight key questions. Diagnostic imaging does not determine suitability for surgery but can guide the planning of surgery in suitable candidates. First-line imaging includes ultrasound and either parathyroid 4DCT or scintigraphy, depending on local availability and expertise. Minimally invasive parathyroidectomy is appropriate in most patients with concordant imaging. Bilateral neck exploration should be considered in those with discordant/negative imaging findings, multi-gland disease and genetic/familial risk factors. Parathyroid surgery, especially re-operative surgery, has better outcomes in the hands of higher volume surgeons. Neuromonitoring is generally not required for initial surgery but should be considered for re-operative surgery. Following parathyroidectomy, calcium and parathyroid hormone levels should be re-checked in the first 24 h and repeated early if there are risk factors for hypocalcaemia. Eucalcaemia at 6 months is consistent with surgical cure; parathyroid hormone levels do not need to be re-checked in the absence of other clinical indications. Longer-term surveillance of skeletal health is recommended. This position statement provides up-to-date guidance on evidence-based best practice surgical and postoperative management of adults with primary hyperparathyroidism.en
dc.language.isoeng
dc.titlePrimary hyperparathyroidism in adults-(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society.en
dc.typeJournal Articleen
dc.identifier.journaltitleClinical Endocrinologyen
dc.identifier.affiliationEndocrinologyen
dc.identifier.affiliationSurgeryen
dc.identifier.affiliationMedicine (University of Melbourne)en
dc.identifier.affiliationSouth Australian Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, South Australiaen
dc.identifier.affiliationDepartment of Surgery, University of Otago, Wellington, New Zealanden
dc.identifier.affiliationDepartment of Endocrinology, St Vincent's Hospital, Fitzroy, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Endocrinology, Royal North Shore Hospital, St Leonards, New South Wales, Australiaen
dc.identifier.affiliationFaculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australiaen
dc.identifier.affiliationPRP Diagnostic Imaging, Sydney, New South Wales, Australiaen
dc.identifier.affiliationClinical Biochemistry Unit, Alfred Pathology Service, Alfred Health, Melbourne, Victoria, Australiaen
dc.identifier.affiliationKolling Institute, University of Sydney, Sydney, New South Wales, Australiaen
dc.identifier.affiliationDepartment of Endocrinology, Alfred Hospital, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Clayton, Victoria, Australiaen
dc.identifier.affiliationCancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, New South Wales, Australiaen
dc.identifier.affiliationNSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, New South Wales, Australiaen
dc.identifier.affiliationDepartment of Surgery, Redland Hospital, Metro South and Faculty of Medicine, University of Queensland, Saint Lucia, Queensland, Australiaen
dc.identifier.affiliationDepartment of Surgery, Logan Hospital, Metro South and School of Medicine and Dentistry, Griffith University, Nathan, Queensland, Australiaen
dc.identifier.affiliationDepartment of Endocrinology, Monash Health, Clayton, Victoria, Australiaen
dc.identifier.affiliationCentre for Endocrinology & Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medicine, Nursing & Health Sciences, School of Clinical Sciences, Monash University, Clayton, Victoria, Australiaen
dc.identifier.affiliationDepartment of Surgery, University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Surgery, St Vincent's Hospital, Fitzroy, Victoria, Australiaen
dc.identifier.affiliationDepartment of Surgery, Royal Children's Hospital, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of General Surgery, The Alfred Hospital, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Endocrine Surgery, Monash University, Victoria, Clayton, Australiaen
dc.identifier.affiliationDepartment of Surgery, The Royal Melbourne Hospital, Melbourne, Victoria, Australiaen
dc.identifier.affiliationEndocrine Surgical Centre, Epworth Hospital Network, Richmond, Victoria, Australiaen
dc.identifier.affiliationDepartment of Diabetes and Endocrinology, Westmead Hospital, New South Wales, Australiaen
dc.identifier.affiliationAdelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australiaen
dc.identifier.affiliationDepartment of General Surgery, Wellington Regional Hospital, Wellington, New Zealanden
dc.identifier.affiliationEndocrine, Diabetes, and Research Centre, Wellington Regional Hospital, Wellington, New Zealanden
dc.identifier.affiliationDepartment of Medical Imaging, St Vincent's Hospital, Fitzroy, Victoria, Australiaen
dc.identifier.affiliationEndocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australiaen
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/34927274/en
dc.identifier.doi10.1111/cen.14650en
dc.type.contentTexten
dc.identifier.orcid0000-0002-1545-0368en
dc.identifier.orcid0000-0001-8261-3457en
dc.identifier.orcid0000-0002-6755-8469en
dc.identifier.orcid0000-0002-0834-1948en
dc.identifier.pubmedid34927274
local.name.researcherFarrell, Stephen G
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptEndocrinology-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

24
checked on Mar 4, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.